TAF1 and leukemia: In MOLM13 leukemia cells, FLT3 inhibitor 3i-1247 was the most potent compound overall, and possessed superb anti-proliferative activity compared to dual FLT3/TAF1 compounds 3i-1246 and 3i-1248 (Fig 3, S1 Fig).